Navigation Links
Revolutionary Simple Pregnancy Blood Test Can Save Both Mother And Child

Pre-eclampsia is a disease that causes high blood pressure in 20th week// of Pregnancy and is a major cause of death of mother and infant in the world. Now a simple test that measures HLA-G levels in blood can predict women who are likely to develop the problem.

Researchers in Canada may have discovered this simple blood test. "We're really excited about this finding," said Clifford Librach, a researcher from Sunnybrook and Women's College Health Sciences Centre. In Toronto "I think it's really an advance in this area and something we hope will prevent this disease."

He further said: "This allows us to be more vigilant and see the woman more often and pick up the problem early enough that it doesn't become a more serious problem for mother and baby."

Pre-eclampsia kills over 20'000 expectant mothers worldwide every year. Pre-eclampsia is unpredictable and can appear suddenly in about one in 12 pregnancies. The blood pressure shoots up in the mothers-to-be and can cause seizures or fits, stroke and kidney related complications. This can result in stillbirth or fetal distress. The condition accounts for more than 15% of all premature births.

Currently there is no test available. "This allows us to be more vigilant and see the woman more often and pick up the problem early enough that it doesn't become a more serious problem for mom and baby," said Librach.

Scientists now believe that they have tracked down the cause of the disease and found this to be a molecule secreted by the placenta. The molecule is called ‘HLA-G molecule ‘ and is a protective substance that helps in preventing the mother's body to reject the unborn child.

Prof Shennan, a Professor of obstetrics at Guy's and St Thomas' hospital in London, added: "This is an important development because it helps to identify which part of the immune system is involved in pre-eclampsia. We've always known that immunology has been important and
'"/>




Page: 1 2

Related medicine news :

1. Revolutionary Pill Cuts Risk of Breast Cancer
2. A Revolutionary New Treatment For Cancer Available In Australia
3. New Revolutionary Drug Could Stop the Spread of HIV
4. Revolutionary New Treatment Plan Developed For Treatment Of Unexplained Symptoms
5. Revolutionary Net To Control Malaria
6. Revolutionary Net To Control Malaria
7. Revolutionary Eye Cancer Treatment
8. Revolutionary Pill Promises Relief for Hay Fever Sufferers
9. Long-Term Survival can be Predicted by a Simple Lung Test
10. Simple Therapy
11. Simple Stroke Prevention is Best

Post Your Comments:
(Date:11/8/2009)...re-USNewswire/ -- The American Public Health Assoc... provisions in the health reform bill passed last ...ll, the House takes important steps toward univers...s and moving our health system from one that focus...ping people healthy," said Georges C. Benjamin, MD...
(Date:11/8/2009)...s Nail Nation,s Job Creators ,, WASHINGTON, Nov... House passage of the health care bill (H.R. 3962)...BE Council) president & CEO Karen Kerrigan iss...ke, those voting for H.R. 3962 voted to burden our...ing taxes and penalties. Even in the best of econo...
(Date:11/8/2009)...ing of biopharmaceuticals to be available at the C... Toronto, ON (PRWEB) Novemb... Therapure Biopharma Inc. today announced that the...pharmaceutical grade freeze dryer and expects to m...) available for contract manufacturing of biopharm...
(Date:11/8/2009)...ispanic health advocates committed to achieving me...TON, Nov. 7 "Tonight th...eard the voice of America,s families by passing th...Senate must deliver, without delay, on the promise...L. Delgado, President and CEO of the National Alli...
(Date:11/8/2009)... Health Care Reform Bill ,, Critical legislat...r all Americans ,, CHICAGO, Nov. 7 /PRNewswire...Representatives passed by a vote of 220-215, criti...ngthen Medicare for seniors and end discrimination...ericans out of affordable health coverage. ,,...
Breaking Medicine News(10 mins):Health News:APHA Applauds Prevention and Wellness Provisions in House Health Reform Bill 2Health News:Therapure Biopharma Inc. Announces Delivery of its First Commercial-Scale Lyophilizer 2Health News:National Alliance for Hispanic Health President and CEO Applauds House Action, Calls on Senate to Pass Health Reform in 2009 2Health News:AARP Illinois Key Vote News Alert 2Health News:AARP Illinois Key Vote News Alert 3
...Va., May 16 CEL-SCI CORPORATION,(Amex: CVM ) rep...s ended,March 31, 2008., Geert Kersten, Chief Exe...e completely focused on getting our cancer therapy...ng facility for,Multikine from which we can supply...
... Clinical Functionality and Innovative Clinical To...formance, LAS VEGAS, May 16 Vital Images, Inc. (...de advanced visualization and,analysis solutions f...th Annual Workstation Face-Off, highlighted,the br...
...ILL, N.C., May 16 Superior launch strategies,allo... as a leader in,crowded markets. To secure "share ...elop specific uptake strategies to support busines...oduct,s,success., "Best Practices for Winning Pro...
... to Visit Omaha to Rally Residents to Eat Right, M...ir Diets, OMAHA, Neb., May 16 The last decade ca... diets -- which seem to go in and out of,fashion l...in overweight or obese., A new campaign crossing ...
...e expands natural killer cells in cord blood more ... News) A treatment that uses natural killer (NK) ...ctively destroys human leukemia cells in mice, res... test mice with aggressive human leukemias, accord...
... following news tips are based on abstracts or pos...rican Society of Clinical Oncology (ASCO) to be he... Study Tracks a Biomarker for Early Detection of ... NYU Cancer Institutes Harvey Pass, M.D., professo...
Other Medicine News:Health News:CEL-SCI Corporation Reports Second Quarter 2008 Financial Results 2Health News:CEL-SCI Corporation Reports Second Quarter 2008 Financial Results 3Health News:CEL-SCI Corporation Reports Second Quarter 2008 Financial Results 4Health News:CEL-SCI Corporation Reports Second Quarter 2008 Financial Results 5Health News:Vital Images Showcases the ViTAL Enterprise Solution at Stanford University's 6th Annual Face-Off 2Health News:Vital Images Showcases the ViTAL Enterprise Solution at Stanford University's 6th Annual Face-Off 3Health News:Global Pharmaceutical Launches: Best Practices for Winning Product Launch Successes 2Health News:Message to Nebraska Residents: Forgo Fad Dieting and Join the Campaign for Healthy Weight 2Health News:Message to Nebraska Residents: Forgo Fad Dieting and Join the Campaign for Healthy Weight 3Health News:New Therapy Kills Human Leukemia Cells in Mice 2Health News:NYU Langone Medical Center's tip sheet to the 44th annual meeting of ASCO 2Health News:NYU Langone Medical Center's tip sheet to the 44th annual meeting of ASCO 3Health News:NYU Langone Medical Center's tip sheet to the 44th annual meeting of ASCO 4
(Date:11/6/2009)...ov. 6 America,s Special... group of mid-market and smaller innovator pharmac...H.R. 3962, the "Affordable Health Care for America.... These smaller companies fear that the cumulativ... hinder their efforts to bring new medicines to ma...
(Date:11/6/2009)...ss., Nov. 6 Facet Solutions, Inc. ...sets of Archus Orthopedics. The acquisition create...erings, intellectual property and clinical experie...in for patients suffering from lumbar spinal steno... Geoff Pardo. "This consolidation further strengt...
(Date:11/6/2009)..., Nov. 6 Boston Scientif...it has reached an agreement in principle with the ...t advisories issued by its Guidant subsidiary in 2...ed prior to Boston Scientific,s 2006 acquisition o...disclosed an investigation by the U.S. Attorney,s ...
Breaking Medicine Technology:Statement of America's Specialty Medicines Companies On House Health Care Bill (H.R. 3962) 2Facet Solutions Acquires Archus Orthopedics 2Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 2Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 3Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 4Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 5Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 6Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 7Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 8Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 9Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 10Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 11Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 12Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 13Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 14Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 15Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 16Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 17IUPUI chemists develop Distributed Drug Discovery 3A Finding drugs for neglected diseases 48927 1IUPUI chemists develop Distributed Drug Discovery 3A Finding drugs for neglected diseases 48927 2IUPUI chemists develop Distributed Drug Discovery 3A Finding drugs for neglected diseases 48927 3Having a higher purpose in life reduces risk of death among older adults 48925 1Having a higher purpose in life reduces risk of death among older adults 48925 2Having a higher purpose in life reduces risk of death among older adults 48925 3They are young and need the job 3A A second chance for dangerous T cells 8838 1They are young and need the job 3A A second chance for dangerous T cells 8838 2They are young and need the job 3A A second chance for dangerous T cells 8838 3
...uticals, Inc. (Nasdaq: IDIX ), a biopharmaceutic...t of drugs for the treatment of human viral and ot...as initiated a proof-of-concept study of IDX184, a...he treatment of HCV under an Investigational New D...Administration (FDA). The study is evaluating IDX1...
...-B(R) for lupus and ABthrax(R) for inhalation anth...on - , , - GSK Phase 3 trial of darapladib underw...provides 2009 financial guidance; expects less tha... Jan. 12 Human Genome Sciences, Inc. (Nasdaq: H...d report on the Company,s progress toward commerci...
Other Medicine Technology:Idenix Pharmaceuticals Initiates Proof-of-Concept Study of IDX184 for the Treatment of Hepatitis C Virus (HCV) 2Idenix Pharmaceuticals Initiates Proof-of-Concept Study of IDX184 for the Treatment of Hepatitis C Virus (HCV) 3Idenix Pharmaceuticals Initiates Proof-of-Concept Study of IDX184 for the Treatment of Hepatitis C Virus (HCV) 4Human Genome Sciences Reports Substantial Progress Toward Commercialization and Announces 2009 Goals at JPMorgan Healthcare Conference 2Human Genome Sciences Reports Substantial Progress Toward Commercialization and Announces 2009 Goals at JPMorgan Healthcare Conference 3Human Genome Sciences Reports Substantial Progress Toward Commercialization and Announces 2009 Goals at JPMorgan Healthcare Conference 4Human Genome Sciences Reports Substantial Progress Toward Commercialization and Announces 2009 Goals at JPMorgan Healthcare Conference 5Human Genome Sciences Reports Substantial Progress Toward Commercialization and Announces 2009 Goals at JPMorgan Healthcare Conference 6Human Genome Sciences Reports Substantial Progress Toward Commercialization and Announces 2009 Goals at JPMorgan Healthcare Conference 7Human Genome Sciences Reports Substantial Progress Toward Commercialization and Announces 2009 Goals at JPMorgan Healthcare Conference 8Human Genome Sciences Reports Substantial Progress Toward Commercialization and Announces 2009 Goals at JPMorgan Healthcare Conference 9
Creatine Kinase Kinetic Reagent
Creatine Kinase-MB (CK-MB)
Magnesium
Glucose UV Liquidplus
Medicine Products: